アクセルベックス List of Products and Services

Our α-GalCer (KRN7000, α-galactosylceramide) is a GMP-compliant product, ensuring high quality and safety. For more details, please refer to the catalog.

• others

"Shin Beck" is a cancer immunotherapy that processes the patient's own cells collected through CART (ascites treatment) and then administers them to the patient to activate immune cells in the body. It is possible to administer the treatment to the patient within a short period (about one week) after receiving the CART waste bag. The activated immune cells (NK and killer T cells) in the body kill tumor cells. [Features] - Activates immune cells in the body - Immune cells (NK and killer T cells) kill tumor cells - Can be administered to the patient within a short period (about one week) *For more details, please refer to the PDF materials or feel free to contact us.

• Other services and technologies

This document introduces the prospects of a preventive and therapeutic vaccine using KRN7000 (a-galactosylceramide: a-GalCer). It includes topics such as "The discovery of the natural compound a-galactosylceramide," "Synthesis of a-GalCer compound (KRN7000)," and "Mechanism of action of a-GalCer." We encourage you to read it. 【Contents】 ■ The discovery of the natural compound a-galactosylceramide (α-GalCer) ■ Synthesis of a-GalCer compound (KRN7000) ■ Mechanism of action of a-GalCer ■ Immunostimulatory effects of a-GalCer and its application in cancer treatment ■ Immunoregulatory effects of a-GalCer and its application in the treatment of allergies, autoimmune diseases, and transplant rejection suppression *For more details, please refer to the PDF document or feel free to contact us.

• others